Literature DB >> 20937880

Glycosylation of surface Ig creates a functional bridge between human follicular lymphoma and microenvironmental lectins.

Vania Coelho1, Sergey Krysov, Amir M Ghaemmaghami, Mohamed Emara, Kathleen N Potter, Peter Johnson, Graham Packham, Luisa Martinez-Pomares, Freda K Stevenson.   

Abstract

Surface Ig (sIg) of follicular lymphoma (FL) is vital for tumor cell survival. We found previously that the Ig in FL is unusual, because the variable region genes carry sequence motifs for N-glycan addition. These are introduced by somatic mutation and are tumor specific. Unexpectedly, added glycans terminate at high mannose, suggesting a potentially important interaction of FL cells with mannose-binding lectins of the innate immune system. We have now identified mannosylated IgM at the surface of primary lymphoma cells. Recombinant lectin domains of the mannose receptor (MR) or DC-SIGN bind mannosylated Igs in vitro and bind to FL cells, signaling sIgM-associated increases in intracellular Ca(2+). Lectins also bind to normal B cells but fail to signal. In contrast, anti-Ig signaled similarly in both FL and normal B cells. Mannosylation patterns were mimicked by FL Ig-derived single-chain Fvs (scFv), providing probes for potential receptors. Mannosylated scFv bound specifically to the lectin domains of the MR and DC-SIGN and blocked signaling. Mannosylated scFv also bound to DC-SIGN on the surface of dendritic cells. This unique lymphoma-specific interaction of sIg with lectins of innate immunity reveals a potential route for microenvironmental support of tumor cells, mediated via the key B-cell receptor.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20937880      PMCID: PMC2972945          DOI: 10.1073/pnas.1009388107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

Review 1.  Cellular origin of human B-cell lymphomas.

Authors:  R Küppers; U Klein; M L Hansmann; K Rajewsky
Journal:  N Engl J Med       Date:  1999-11-11       Impact factor: 91.245

2.  In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death.

Authors:  K P Lam; R Kühn; K Rajewsky
Journal:  Cell       Date:  1997-09-19       Impact factor: 41.582

Review 3.  Glycosylation: heterogeneity and the 3D structure of proteins.

Authors:  P M Rudd; R A Dwek
Journal:  Crit Rev Biochem Mol Biol       Date:  1997       Impact factor: 8.250

4.  A cysteine-rich domain of the "mannose" receptor mediates GalNAc-4-SO4 binding.

Authors:  D J Fiete; M C Beranek; J U Baenziger
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

Review 5.  The biology of human lymphoid malignancies revealed by gene expression profiling.

Authors:  Louis M Staudt; Sandeep Dave
Journal:  Adv Immunol       Date:  2005       Impact factor: 3.543

6.  High frequency of somatically mutated IgM molecules in the human adult blood B cell repertoire.

Authors:  J H van Es; F H Meyling; T Logtenberg
Journal:  Eur J Immunol       Date:  1992-10       Impact factor: 5.532

7.  Involvement of the bcl-2 gene in human follicular lymphoma.

Authors:  Y Tsujimoto; J Cossman; E Jaffe; C M Croce
Journal:  Science       Date:  1985-06-21       Impact factor: 47.728

8.  Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals.

Authors:  J Limpens; R Stad; C Vos; C de Vlaam; D de Jong; G J van Ommen; E Schuuring; P M Kluin
Journal:  Blood       Date:  1995-05-01       Impact factor: 22.113

9.  Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells.

Authors:  Sandeep S Dave; George Wright; Bruce Tan; Andreas Rosenwald; Randy D Gascoyne; Wing C Chan; Richard I Fisher; Rita M Braziel; Lisa M Rimsza; Thomas M Grogan; Thomas P Miller; Michael LeBlanc; Timothy C Greiner; Dennis D Weisenburger; James C Lynch; Julie Vose; James O Armitage; Erlend B Smeland; Stein Kvaloy; Harald Holte; Jan Delabie; Joseph M Connors; Peter M Lansdorp; Qin Ouyang; T Andrew Lister; Andrew J Davies; Andrew J Norton; H Konrad Muller-Hermelink; German Ott; Elias Campo; Emilio Montserrat; Wyndham H Wilson; Elaine S Jaffe; Richard Simon; Liming Yang; John Powell; Hong Zhao; Neta Goldschmidt; Michael Chiorazzi; Louis M Staudt
Journal:  N Engl J Med       Date:  2004-11-18       Impact factor: 91.245

10.  Glycosylation of a VH residue of a monoclonal antibody against alpha (1----6) dextran increases its affinity for antigen.

Authors:  S C Wallick; E A Kabat; S L Morrison
Journal:  J Exp Med       Date:  1988-09-01       Impact factor: 14.307

View more
  62 in total

Review 1.  When Glycosylation Meets Blood Cells: A Glance of the Aberrant Glycosylation in Hematological Malignancies.

Authors:  Huining Su; Mimi Wang; Xingchen Pang; Feng Guan; Xiang Li; Ying Cheng
Journal:  Rev Physiol Biochem Pharmacol       Date:  2021       Impact factor: 5.545

Review 2.  N-glycoprotein macroheterogeneity: biological implications and proteomic characterization.

Authors:  Lucia F Zacchi; Benjamin L Schulz
Journal:  Glycoconj J       Date:  2015-12-05       Impact factor: 2.916

3.  DC-SIGN-expressing macrophages trigger activation of mannosylated IgM B-cell receptor in follicular lymphoma.

Authors:  Rada Amin; Frédéric Mourcin; Fabrice Uhel; Céline Pangault; Philippe Ruminy; Loic Dupré; Marion Guirriec; Tony Marchand; Thierry Fest; Thierry Lamy; Karin Tarte
Journal:  Blood       Date:  2015-08-13       Impact factor: 22.113

Review 4.  T cells modulate glycans on CD43 and CD45 during development and activation, signal regulation, and survival.

Authors:  Mary C Clark; Linda G Baum
Journal:  Ann N Y Acad Sci       Date:  2012-01-30       Impact factor: 5.691

5.  Tumor cells express pauci- and oligomannosidic N-glycans in glycoproteins recognized by the mannose receptor (CD206).

Authors:  Kathrin Stavenhagen; Lisa C Laan; Chao Gao; Akul Y Mehta; Jamie Heimburg-Molinaro; Jonathan N Glickman; Irma van Die; Richard D Cummings
Journal:  Cell Mol Life Sci       Date:  2021-06-05       Impact factor: 9.261

6.  Origin and migration of follicular lymphoma cells.

Authors:  Philip M Kluin
Journal:  Haematologica       Date:  2013-09       Impact factor: 9.941

7.  Idiotype vaccines for lymphoma: Potential factors predicting the induction of immune responses.

Authors:  Susana Inoges; Ascension Lopez-Diaz de Cerio; Helena Villanueva; Fernando Pastor; Elena Soria; Maurizio Bendandi
Journal:  World J Clin Oncol       Date:  2011-06-10

8.  Activation of T-cell receptor signaling in peripheral T-cell lymphoma cells plays an important role in the development of lymphoma-associated hemophagocytosis.

Authors:  Jun An; Hiroshi Fujiwara; Koichiro Suemori; Toshiyuki Niiya; Taichi Azuma; Kazushi Tanimoto; Toshiki Ochi; Yoshiki Akatsuka; Junichi Mineno; Hidetoshi Ozawa; Fumihiko Ishikawa; Kiyotaka Kuzushima; Masaki Yasukawa
Journal:  Int J Hematol       Date:  2011-01-13       Impact factor: 2.490

Review 9.  Pathogenic B-cell receptor signaling in lymphoid malignancies: New insights to improve treatment.

Authors:  Ryan M Young; James D Phelan; Wyndham H Wilson; Louis M Staudt
Journal:  Immunol Rev       Date:  2019-09       Impact factor: 12.988

10.  CREBBP gene mutations are frequently detected in in situ follicular neoplasia.

Authors:  Janine Schmidt; Joan Enric Ramis-Zaldivar; Irina Bonzheim; Julia Steinhilber; Inga Müller; Andrea Haake; Shan Chi Yu; Mark Raffeld; Falko Fend; Itziar Salaverria; Reiner Siebert; Elaine S Jaffe; Leticia Quintanilla-Martinez
Journal:  Blood       Date:  2018-11-06       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.